Evidence map›Paper›PMID 39976643›Full record

ReviewApplied microbiology and biotechnology2025

Enzymes that catalyze cyclization of β-1,2-glucans.

Masahiro Nakajima, Sei Motouchi, Nobukiyo Tanaka, Tomoko Masaike

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masahiro NakajimaDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. m-nakajima@rs.tus.ac.jp.ORCID http://orcid.org/0000-0002-3182-0859
Sei MotouchiDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.ORCID http://orcid.org/0009-0007-1632-4826
Nobukiyo TanakaDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.ORCID http://orcid.org/0000-0002-1845-5738
Tomoko MasaikeDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan. tmasaike@rs.tus.ac.jp.ORCID http://orcid.org/0000-0003-3290-1893

Funding

JSPS KAKENHI 23K05041
6 · The paper itself

Abstract

β-1,2-Glucans are physiologically important polymers for interactions such as symbiosis and pathogenesis between organisms and adaptation to environmental changes. However, rarity of β-1,2-glucans in nature limits exploration of related enzymes. Recently, many β-1,2-glucan-degrading enzymes have been found after identification of a novel phosphorylase acting on β-1,2-glucooligosaccharides. The expansion of the repertoire has reached revelation of the cyclization mechanism of cyclic β-1,2-glucan synthase and led to finding of new enzymes catalyzing cyclization of β-1,2-glucans in a manner different from cyclic β-1,2-glucan synthase. In this review, we mainly focus on newly found enzymes that catalyze cyclization of β-1,2-glucans along with existence of β-1,2-glucan-associated carbohydrates in nature and introduction of the repertoire of β-1,2-glucan-degrading enzymes. KEY POINTS: • Newly found domain which cyclizes β-1,2-glucan created a new glycoside hydrolase family. • Cyclization is performed with a unique mechanism. • α-1,6-Cyclized β-1,2-glucan is produced by an enzyme in another newly found family.

Indexed as

beta-GlucansGlycoside HydrolasesCyclizationGlucosyltransferasesbeta-GlucansGlucosyltransferasesGlycoside HydrolasesCyclic β-1,2-glucan synthaseGlycoside hydrolase familyOsmoregulated periplasmic glucansTransglycosylationβ-1,2-Glucan

Identifiers

PMID39976643
PMCPMC11842490

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.